# Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer

> **NCT01004510** · PHASE2 · TERMINATED · sponsor: **Peter Bushunow MD** · enrollment: 3 (actual)

## Conditions studied

- Malignant Pleural Effusion
- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT01004510
- **Lead sponsor:** Peter Bushunow MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-09
- **Final completion:** 2011-04
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** failure to accrue projected number of patients
- **Last updated:** 2012-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004510, "Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01004510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*